Webinar: Closing the Gaps in Multiple Myeloma with Data and AI

Despite significant advancements in treatment over the past decade, the 5-year survival of multiple myeloma stands at 58% for all SEER stages. We believe that a deeper understanding of both patients and the comparative effectiveness of treatments, alongside novel drugs, is essential for improving outcomes in this complex disease.

Join real-world experts at TriNetX and Databricks as we examine how rich and timely clinical data, unified in a research-ready environment, can provide clinical researchers with the best opportunity to accelerate time-to-insight and influence outcomes.


Multiple Myeloma: Progress Made, Progress Needed

Luis Arthur Flores Pelloso MD, PhD, Executive Medical Director, TA Lead for HemOnc, PPD, part of Thermo Fisher Scientific

Deep Data for a Complex Disease

Jeff Graham, Vice President Real-World Data & Innovation, TriNetX

Scaling Success with the Right Data and Technology

Michael Sanky, Global Industry Lead, Healthcare & Life Sciences, Databricks


During this session, we’ll:

  • Explore a recent success in sourcing, curating, and inferring key scores from this data, based on 100,000 de-identified U.S. patients diagnosed since 2010.
  • Showcase how organizations can de-identify, gather and harmonize millions of treatment-related observations.
  • Demonstrate how to organize data in carefully documented, analysis-ready tables using the power of Databricks Lakehouse.
  • Examine how clinical expertise, machine learning experience, and best-in-class technology can converge to better understand disease progression (measured by ECOG scores) for thousands of patients, enabling outcome-oriented evidence generated at scale.
  • Present lessons learned applicable to a wide array of clinical data curation and evidence generation projects.


    Complete the form below to stream our webinar:


    By submitting, I expressly consent to sharing my information with Databricks and the co-sponsors to use in accordance with their privacy policy. If subscribing to marketing emails, I understand I can update my preferences at any time. Databricks Privacy Policy

    TriNetX needs the contact information you provide to us to send updates about this webinar and, if subscribing to marketing emails, general marketing emails from which you may opt out at any time. For opt-out information, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.